LU86289A1 - Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle - Google Patents

Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle Download PDF

Info

Publication number
LU86289A1
LU86289A1 LU86289A LU86289A LU86289A1 LU 86289 A1 LU86289 A1 LU 86289A1 LU 86289 A LU86289 A LU 86289A LU 86289 A LU86289 A LU 86289A LU 86289 A1 LU86289 A1 LU 86289A1
Authority
LU
Luxembourg
Prior art keywords
formulation according
dihydroergotamine
fat
dergocrine
substance
Prior art date
Application number
LU86289A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86289A1 publication Critical patent/LU86289A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU86289A 1985-02-05 1986-02-04 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle LU86289A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8502889 1985-02-05
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB8517604 1985-07-12
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
LU86289A1 true LU86289A1 (fr) 1986-09-02

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86289A LU86289A1 (fr) 1985-02-05 1986-02-04 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle

Country Status (24)

Country Link
JP (1) JPS61183225A (es)
KR (1) KR920010388B1 (es)
AU (1) AU597570B2 (es)
BE (1) BE904152A (es)
CA (1) CA1263087A (es)
CH (1) CH667592A5 (es)
CY (1) CY1604A (es)
DE (1) DE3602577A1 (es)
DK (1) DK167138B1 (es)
ES (1) ES8800040A1 (es)
FR (1) FR2576787B1 (es)
GB (1) GB2170407B (es)
GR (1) GR860310B (es)
HK (1) HK57191A (es)
HU (1) HU195729B (es)
IE (1) IE59293B1 (es)
IT (1) IT1191255B (es)
LU (1) LU86289A1 (es)
NL (1) NL8600161A (es)
NZ (1) NZ215020A (es)
PH (1) PH23384A (es)
PT (1) PT81954B (es)
SE (1) SE8600496L (es)
SG (1) SG56191G (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
SI8710406B (sl) * 1987-03-11 1998-08-31 Lek Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
CA2408541C (en) * 2000-05-12 2009-07-28 Meracol Corporation Limited Treating eczema and/or psoriasis
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2001085162A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating irritable bowel syndrome or disease
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
IT8647620A0 (it) 1986-02-05
ES8800040A1 (es) 1987-10-16
PH23384A (en) 1989-07-26
CH667592A5 (de) 1988-10-31
NZ215020A (en) 1989-07-27
GB8602602D0 (en) 1986-03-12
CA1263087A (en) 1989-11-21
IE59293B1 (en) 1994-02-09
FR2576787B1 (fr) 1990-01-12
DK167138B1 (da) 1993-09-06
KR920010388B1 (ko) 1992-11-27
DE3602577A1 (de) 1986-08-28
IE860291L (en) 1986-08-05
HUT41984A (en) 1987-06-29
AU597570B2 (en) 1990-06-07
GR860310B (en) 1986-05-27
PT81954A (en) 1986-03-01
HK57191A (en) 1991-08-02
AU5294286A (en) 1986-08-14
BE904152A (fr) 1986-08-04
DK52086D0 (da) 1986-02-03
CY1604A (en) 1992-04-03
GB2170407B (en) 1988-10-26
NL8600161A (nl) 1986-09-01
SE8600496L (sv) 1986-08-06
PT81954B (pt) 1988-07-01
IT1191255B (it) 1988-02-24
HU195729B (en) 1988-07-28
KR860006265A (ko) 1986-09-09
DK52086A (da) 1986-08-06
ES551635A0 (es) 1987-10-16
GB2170407A (en) 1986-08-06
FR2576787A1 (fr) 1986-08-08
SG56191G (en) 1991-08-23
SE8600496D0 (sv) 1986-02-04
JPS61183225A (ja) 1986-08-15

Similar Documents

Publication Publication Date Title
JP5660544B2 (ja) 安定性が向上したアムロジピン及びロサルタンを含む固形薬剤的組成物
JP2001500883A (ja) 低脂質値のためのシブトラミン類似物の使用
EP1108424B2 (fr) Comprimé matriciel permettant la libération prolongée de trimétazidine après administration par voie orale
CH679011A5 (es)
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
JPH11512115A (ja) 経口投与用製剤組成物
LU86289A1 (fr) Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle
TW200831134A (en) Phenylalkyl carbamate compositions
FR2600253A1 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene
JPH085787B2 (ja) 痴呆及び脳血管障害予防・治療剤並びに血小板凝集抑制剤
GB2154874A (en) Bromocriptine compositions
BE1007024A5 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1, selective.
BE1010972A6 (fr) Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition.
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
FR2604902A1 (fr) Compositions pharmaceutiques a liberation prolongee
JP4945043B2 (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤
EP0966276B1 (fr) Utilisation d'agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
FR2773489A1 (fr) Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
LU85331A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
CN114746092A (zh) D-苯丙胺化合物、组合物、以及制备和使用它们的方法
FR2820423A1 (fr) Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
FR2589732A1 (fr) Nouvelle formulation a liberation prolongee a base de pindolol
FR2861299A1 (fr) Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
WO2003057198A1 (fr) Compositions pharmaceutiques a liberation modifiee
FR2560047A1 (fr) Compositions de bromocriptine